We are live on ! Find out more
RCM

Riverhead Capital Management Portfolio holdings

AUM $2.71B Turnover 9.18%
1-Year Est. Return 2.34%
This Fund
S&P 500
This Quarter Est. Return
+1.42%
1 Year Est. Return
+2.34%
3 Year Est. Return
+45.71%
5 Year Est. Return
+71.12%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
-$3.34M
Cap. Flow
-$19.3M
Cap. Flow %
-0.71%
Top 10 Hldgs %
12.6%
Holding
1,579
New
62
Increased
514
Reduced
352
Closed
83
Avg Time Held
3.7 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$20.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$9.12M
3
MSFT icon
Microsoft
MSFT
+$7.23M
4
T icon
AT&T
T
+$6.88M
5
C icon
Citigroup
C
+$6.4M

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$7.59M
2
RHI icon
Robert Half
RHI
+$7.08M
3
FTNT icon
Fortinet
FTNT
+$6.33M
4
ALLY icon
Ally Financial
ALLY
+$5.86M
5
FFIV icon
F5
FFIV
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 15.18%
3 Healthcare 13.24%
4 Industrials 10.97%
5 Consumer Discretionary 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CLX icon
26
Clorox
CLX
$12.7B
$15.4M 0.57%
101,184
-4,460
-4% -$705K
2013 Q2
25 quarters
MA icon
27
Mastercard
MA
$545B
$15.1M 0.56%
55,486
+5,355
+11% +$1.48M
2013 Q2
25 quarters
BAC icon
28
Bank of America
BAC
$325B
$14.6M 0.54%
499,929
+89,928
+22% +$2.59M
2013 Q2
25 quarters
UNH icon
29
UnitedHealth
UNH
$305B
$14.4M 0.53%
66,401
+7,065
+12% +$1.7M
2013 Q2
25 quarters
GOOG icon
30
Alphabet (Google) Class C
GOOG
$3.25T
$14.1M 0.52%
231,920
+56,400
+32% +$3.34M
2013 Q2
25 quarters
TMO icon
31
Thermo Fisher Scientific
TMO
$248B
$13.9M 0.51%
47,772
+494
+1% +$141K
2013 Q2
25 quarters
AMGN icon
32
Amgen
AMGN
$236B
$13.1M 0.48%
67,452
+3,576
+6% +$686K
2013 Q2
25 quarters
MSI icon
33
Motorola Solutions
MSI
$86B
$13M 0.48%
76,007
-4,400
-5% -$755K
2013 Q2
25 quarters
AVGO icon
34
Broadcom
AVGO
$1.45T
$12.9M 0.48%
468,130
+83,970
+22% +$2.39M
2018 Q2
5 quarters
BIIB icon
35
Biogen
BIIB
$36.9B
$12.6M 0.47%
54,118
-9,931
-16% -$2.31M
2013 Q2
25 quarters
INTC icon
36
Intel
INTC
$273B
$12.6M 0.46%
243,920
-49,692
-17% -$2.44M
2013 Q2
25 quarters
TGT icon
37
Target
TGT
$75.3B
$12.5M 0.46%
117,219
+1,899
+2% +$181K
2013 Q2
25 quarters
CMI icon
38
Cummins
CMI
$55.3B
$12.4M 0.46%
76,495
-15,293
-17% -$2.45M
2013 Q2
25 quarters
IVV icon
39
iShares Core S&P 500 ETF
IVV
$802B
$12.3M 0.45%
41,084
-10,803
-21% -$3.21M
2018 Q2
5 quarters
SYY icon
40
Sysco
SYY
$38.5B
$11.9M 0.44%
150,217
+14,077
+10% +$1.03M
2013 Q2
25 quarters
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$11.5M 0.42%
38,718
+6,200
+19% +$1.83M
2019 Q1
2 quarters
BMY icon
42
Bristol-Myers Squibb
BMY
$120B
$11.4M 0.42%
225,463
+70,818
+46% +$3.33M
2017 Q3
8 quarters
AMAT icon
43
Applied Materials
AMAT
$240B
$10.9M 0.4%
219,250
+9,013
+4% +$435K
2013 Q2
25 quarters
GSLC icon
44
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$13.7B
$10.7M 0.4%
179,397
+1,886
+1% +$112K
2016 Q4
11 quarters
GILD icon
45
Gilead Sciences
GILD
$206B
$10.3M 0.38%
163,064
+35,850
+28% +$2.34M
2013 Q2
25 quarters
MET icon
46
MetLife
MET
$60.1B
$10.3M 0.38%
217,796
-159,210
-42% -$7.59M
2013 Q2
25 quarters
XRX icon
47
Xerox
XRX
$120M
$10.2M 0.38%
342,691
+111,450
+48% +$3.49M
2013 Q2
25 quarters
ORCL icon
48
Oracle
ORCL
$315B
$10M 0.37%
181,338
+47,721
+36% +$2.64M
2013 Q2
25 quarters
FFIV icon
49
F5
FFIV
$17.3B
$10M 0.37%
71,016
-33,564
-32% -$4.64M
2013 Q2
25 quarters
DAL icon
50
Delta Air Lines
DAL
$52.6B
$9.8M 0.36%
170,453
+30,219
+22% +$1.79M
2013 Q4
23 quarters

Similar funds

Riverhead Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Riverhead Capital Management held 1,579 positions worth $2.71B, down 0.12% from $2.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Riverhead Capital Management's Q3 2019 filing shows 62 new, 514 increased, 352 reduced and 83 closed positions. Its largest new stake was iShares Russell 2000 ETF: 132,000 shares worth $20M. The largest sale was MetLife, an estimated $7.59M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Riverhead Capital Management's largest Q3 2019 buy was iShares Russell 2000 ETF: 132,000 shares worth $20M.
  • Riverhead Capital Management added most to Johnson & Johnson in Q3 2019, an estimated $9.12M increase.
  • Riverhead Capital Management's biggest Q3 2019 reduction was MetLife, cutting an estimated $7.59M.
  • Riverhead Capital Management fully exited Booz Allen Hamilton in Q3 2019, selling an estimated $1.68M.
  • Riverhead Capital Management's ten largest holdings make up 13% of its $2.71B portfolio in Q3 2019.
  • Riverhead Capital Management opened 62 new positions and closed 83 in Q3 2019.
  • Riverhead Capital Management's portfolio value fell 0.12% quarter-over-quarter to $2.71B.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.